Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The collaboration between CORONA and Ferring will cater to patients across India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
The partnership will capitalize on the combined capabilities of the two organizations
Subscribe To Our Newsletter & Stay Updated